Benzodiazepines, often called benzos, are commonly prescribed for anxiety, panic disorders, insomnia, seizures, muscle spasms, and certain other medical conditions. Medications like Xanax, Ativan, Klonopin, and Valium can be effective when appropriately prescribed, but regular use can also lead to physical dependence. Over time, some patterns of benzo use can shift from medical treatment into misuse or addiction, sometimes without a person realizing how much their relationship with the medication has changed.
Physical dependence does not automatically mean someone has a benzodiazepine addiction. A person can become physically dependent while taking benzodiazepines exactly as prescribed. Addiction involves a broader pattern that can include loss of control, cravings, compulsive use, unsuccessful attempts to stop, or continued use despite significant consequences.
Brooks Healing Center provides benzodiazepine detox in Tennessee and continued addiction treatment for adults who need support with benzodiazepine dependence, misuse, withdrawal, or a benzodiazepine-related substance use disorder. Located on our 36-acre campus in Normandy, Tennessee, between Nashville and Chattanooga, Brooks provides medical detox and stabilization, residential addiction treatment, individualized therapy, support for appropriate co-occurring mental health concerns, and continued care through our Partial Hospitalization Program (PHP) and sober living.
| Brooks Program / Level of Care | What It Provides | When It May Be Appropriate |
|---|---|---|
| Benzodiazepine Detox | Clinical assessment, withdrawal monitoring, stabilization, symptom management, and individualized medical planning. | When significant physical dependence, previous difficult withdrawal, high-dose or frequent use, polysubstance use, or other medical or psychiatric concerns make structured withdrawal care appropriate. |
| Residential Treatment | 24-hour structure with therapy, recovery education, mental health support, relapse prevention, and continued stabilization. | When benzodiazepine misuse or addiction requires continued treatment after withdrawal stabilization or is difficult to interrupt outside a structured setting. |
| Behavioral & Mental Health Treatment | Therapy addressing anxiety, coping, cravings, trauma, relapse patterns, sleep, and circumstances surrounding continued benzodiazepine use. | When benzodiazepines have become intertwined with anxiety, panic, trauma, insomnia, stress, or other mental health concerns. |
| Partial Hospitalization Program (PHP) | Intensive daytime clinical care with therapy, recovery support, medication management when appropriate, and increasing independence. | After residential treatment or when someone is medically stable but continues to need substantial treatment structure. |
| Sober Living | Structured, substance-free housing with accountability, routine, peer support, and increasing independence. | For eligible individuals who no longer require intensive clinical treatment but continue to benefit from a recovery-focused living environment. |
A benzodiazepine is a class of prescription medication that slows activity in the central nervous system. These drugs work by increasing the effect of GABA, a neurotransmitter that helps calm brain activity. Because of this, benzodiazepines can reduce anxiety, relax muscles, prevent seizures, promote sleep, and provide sedation in certain medical settings.
Benzodiazepines are often called benzos. Many guidelines recommend relatively short treatment durations for common indications when possible because physical dependence can develop with regular use, although the appropriate duration depends on the medication, condition being treated, and individual medical needs.
Benzodiazepines may be prescribed to treat:
The appropriate medication, dose, and duration depend on the individual medical situation. Someone who takes benzodiazepines regularly should not suddenly stop simply because they learn that physical dependence is possible.
| Benzodiazepine | Brand Name(s) | Common Use | Notes |
|---|---|---|---|
| Diazepam | Valium | Anxiety, muscle spasms, seizures, withdrawal management | Long-acting benzodiazepine |
| Alprazolam | Xanax® | Anxiety and panic disorders | Shorter acting than diazepam and associated with significant withdrawal risk when physical dependence develops |
| Lorazepam | Ativan® | Anxiety, acute agitation, seizures, and other clinical uses | Intermediate-acting benzodiazepine |
| Clonazepam | Klonopin® | Seizure disorders and panic disorder | Longer acting than alprazolam |
| Temazepam | Restoril® | Insomnia | Primarily prescribed for sleep |
| Oxazepam | Serax® | Anxiety and alcohol withdrawal | Used in selected clinical circumstances |
| Chlordiazepoxide | Librium® | Alcohol withdrawal and anxiety | Commonly associated with alcohol-withdrawal management |
| Midazolam | Versed® | Medical and procedural sedation | Primarily used in medical settings |
Tablet colors and shapes can vary by manufacturer and should not be relied on to verify whether a pill is legitimate.
Many benzodiazepines can look similar, and pills obtained outside a licensed pharmacy can be manufactured to imitate legitimate prescription tablets. Not knowing exactly what a pill contains can increase both overdose and withdrawal risk.
Brooks’ guide to anti-anxiety medication names and identifiers provides more information about commonly prescribed medications and the limits of identifying pills by appearance alone.
Counterfeit pills create an additional concern. Brooks’ bromazolam guide explains how an illicit designer benzodiazepine can appear in tablets sold as Xanax or other medications. Counterfeit pills may also contain fentanyl or multiple substances, making their effects much less predictable.
Yes, benzodiazepines can become addictive, but addiction and physical dependence are not the same thing.
The FDA warns about benzodiazepine risks including misuse, addiction, physical dependence, and withdrawal. Physical dependence can develop even when benzodiazepines are taken exactly as prescribed and does not by itself mean someone has developed addiction.
As tolerance and physical dependence develop, stopping or significantly reducing a medication can trigger withdrawal. A substance use disorder involves a broader pattern of impaired control, harmful consequences, cravings, or other behavioral symptoms.
What has historically been called benzodiazepine abuse generally refers to taking the medication outside the prescribed plan, such as taking larger doses, using it more frequently, obtaining pills from unverified sources, or combining benzodiazepines with other substances for their intoxicating effects.
Benzodiazepine dependence can develop without misuse. A person may take a prescription exactly as directed and still develop physiological adaptation that causes withdrawal when the dose is reduced or missed.
The current ASAM benzodiazepine tapering guideline specifically distinguishes physical dependence from benzodiazepine use disorder. Someone can therefore require careful medical support for benzodiazepine withdrawal without necessarily meeting criteria for addiction.
It may be time to seek help if:
Early support can make withdrawal safer and help determine whether the primary concern is physical dependence, a benzodiazepine-related substance use disorder, another underlying condition, or a combination of these factors.
Benzo withdrawal symptoms can range from uncomfortable to life-threatening. Symptoms depend on the type of benzodiazepine involved, dose, frequency, how long it has been used, previous withdrawal history, and whether alcohol, opioids, or other substances are also involved.
The nervous system adapts to repeated benzodiazepine exposure. When someone who has become physically dependent suddenly stops or reduces the medication too rapidly, that adaptation can produce significant withdrawal symptoms.
Common symptoms of benzodiazepine withdrawal can include:
More severe benzodiazepine withdrawal can include confusion, hallucinations, delirium, or seizures.
The FDA specifically warns that abrupt discontinuation or excessively rapid dose reduction can cause serious withdrawal reactions, including seizures that can be life-threatening.
The benzodiazepine withdrawal timeline can vary significantly.
Shorter-acting benzodiazepines can produce symptoms sooner after a missed or reduced dose, while symptoms associated with longer-acting medications may emerge later. Current ASAM guidance emphasizes monitoring the patient’s individual response rather than using one predetermined withdrawal timeline for everyone.
| Phase | What May Occur |
|---|---|
| Early Withdrawal | Anxiety, restlessness, insomnia, irritability, tremor, or return of symptoms the medication had previously been treating. |
| Acute Withdrawal | Anxiety, panic symptoms, sweating, nausea, muscle discomfort, sleep disruption, sensory sensitivity, and nervous-system hyperactivity may become more noticeable. |
| Severe Withdrawal | Some people may develop confusion, hallucinations, delirium, seizures, or other complications requiring immediate medical attention. |
| Later Recovery | Anxiety, sleep disruption, mood changes, concentration problems, and other symptoms may improve gradually. |
| Protracted Withdrawal | Some people report symptoms continuing for weeks or months after the acute phase, particularly after long-term benzodiazepine exposure. |
A gradual medically supervised taper can reduce withdrawal risk, but there is no single taper or withdrawal schedule that works for every person.
Yes. Severe benzodiazepine withdrawal can be life-threatening, especially when someone with established physical dependence suddenly stops or rapidly reduces the medication.
Seizures and delirium are among the most serious complications. Someone experiencing a seizure, severe confusion, hallucinations, loss of consciousness, severe agitation, difficulty breathing, or other rapidly worsening symptoms should receive emergency medical care.
Some people experience lingering symptoms after the most acute withdrawal period. The FDA has received reports of withdrawal symptoms continuing for months, and the ASAM benzodiazepine tapering guideline recognizes that some long-term patients may need a taper extending over many months.
Persistent anxiety, sleep disruption, cognitive symptoms, mood changes, sensory symptoms, or other concerns should be evaluated individually. They should not automatically be attributed to withdrawal because the condition originally treated with the benzodiazepine may also return or continue.
How long benzos stay in the body depends on the specific medication, dose, frequency, duration of use, metabolism, and type of drug test.
Some benzodiazepines are shorter acting, while others such as diazepam and its active metabolites can remain in the body much longer. Blood, urine, saliva, and hair testing also have different detection windows.
Even after a benzodiazepine or its metabolites are no longer detectable by a particular test, withdrawal symptoms can continue as the nervous system readjusts. Drug detection time and withdrawal duration are not the same thing.
Benzo detox is not the same as detoxing from many other substances. Stopping benzodiazepines suddenly after physical dependence develops can be dangerous and, in some cases, life-threatening.
Medical withdrawal management may involve:
The purpose is to stabilize the nervous system and reduce avoidable withdrawal risk rather than simply getting the medication “out of the body” as quickly as possible.
There is no standard benzodiazepine taper schedule that is appropriate for every patient.
The 2025 Joint Clinical Practice Guideline on Benzodiazepine Tapering recommends starting gradually and adjusting the pace according to symptoms, medical needs, and patient response. For many stable patients, the guideline suggests that an initial reduction might begin around 5% to 10% of the current dose every two to four weeks, but some people need smaller reductions, longer pauses, or a substantially slower process.
That recommendation should not be interpreted as a fixed Brooks detox schedule. Someone with high-dose nonmedical use, previous seizures, an uncertain illicit pill supply, polysubstance dependence, or other significant risks may require a different stabilization strategy and level of care.
Likewise, someone who has taken a stable benzodiazepine prescription for years may need a taper that continues long after a short-term detox or residential stay has ended.
A higher level of withdrawal support may be appropriate when there is:
The appropriate level of care depends on the complete clinical picture rather than any one factor.
Brooks’ medical detox program in Tennessee provides 24-hour access to medical and clinical support for appropriate patients at our Normandy campus.
Assessment may consider:
The goal is not to force every patient through the fastest possible benzodiazepine taper. The immediate goal is to promote safety, stabilize withdrawal, identify other treatment needs, and develop an appropriate plan for continued care.
Benzo rehab goes beyond detox. Effective benzodiazepine addiction treatment addresses physical stabilization as well as the underlying reasons problematic benzodiazepine use continued, such as anxiety, trauma, sleep disorders, emotional distress, other substance use, or established behavioral patterns.
Treatment may include:
Recovery focuses on rebuilding stability without relying on problematic benzodiazepine use as the primary way to cope.
After withdrawal stabilization, appropriate patients can continue into residential addiction treatment at Brooks.
Residential treatment provides a structured 24-hour environment where patients can focus on recovery while addressing the behavioral and psychological aspects of substance use. Brooks’ residential program also allows clinicians to continue evaluating anxiety, sleep, trauma, relationships, relapse patterns, and other factors that may influence recovery.
The presence of physical benzodiazepine dependence by itself does not automatically mean someone needs addiction rehab. Residential treatment becomes particularly relevant when there is also misuse, a substance use disorder, polysubstance use, repeated relapse, significant co-occurring needs, or a need for greater treatment structure.
Treatment is individualized, but several forms of therapy can help someone develop alternatives to problematic benzodiazepine use and address the conditions that may have contributed to continued use.
Cognitive Behavioral Therapy (CBT) helps patients identify and modify unhelpful thought patterns and behaviors. For someone recovering from problematic benzodiazepine use, CBT can help identify anxiety triggers, challenge automatic responses, improve coping, and develop alternatives to using medication outside the prescribed treatment plan.
Experiential therapy uses structured activities to help patients express and process emotions while developing greater self-awareness and healthier coping strategies.
When trauma is relevant to the treatment plan, trauma-informed therapy can help address trauma-related symptoms without assuming trauma is responsible for every person’s benzodiazepine use.
Some people began taking benzodiazepines because of legitimate anxiety, panic, insomnia, trauma-related symptoms, or another mental health condition. Removing problematic benzodiazepine use without addressing the original concern can leave someone without the coping strategy they had depended on.
Brooks provides dual-diagnosis treatment for appropriate co-occurring mental health concerns that can be safely managed within our addiction-treatment environment. Patients struggling with persistent anxiety may also receive treatment planning that addresses generalized anxiety disorder when clinically appropriate.
Mixing benzodiazepines with other central nervous system depressants can significantly increase risk.
The FDA warns that misuse of benzodiazepines with opioids, alcohol, or other substances can result in overdose or death. Opioids and benzodiazepines can both contribute to sedation and respiratory depression, while simultaneous physical dependence on alcohol and benzodiazepines can create a more complicated withdrawal picture.
Counterfeit pills add another concern. A tablet sold as Xanax may contain an illicit benzodiazepine such as bromazolam, fentanyl, or other substances that the person did not expect.
This is why treatment assessment needs to ask not only how much Xanax someone says they are taking, but also where the medication came from and whether the contents are actually known.
No. Naloxone, commonly known by the brand name Narcan, does not reverse benzodiazepine effects.
However, if someone who has taken benzodiazepines is unconscious, has slow or abnormal breathing, or may have been exposed to fentanyl or another opioid, give naloxone if it is available and call 911. Naloxone can reverse the opioid component of a mixed overdose even though it does not reverse the benzodiazepine itself.
Recovery does not necessarily end when acute withdrawal is stabilized.
Someone may still need support for anxiety, sleep, cravings, coping, relationships, emotional regulation, other substance use, or a longer outpatient benzodiazepine taper established by the appropriate prescriber.
Brooks’ Partial Hospitalization Program provides intensive daytime clinical treatment at the Normandy campus for medically stable patients who continue to need significant structure after residential care.
PHP can include therapy, recovery education, relapse-prevention planning, medication management when appropriate, and support for appropriate co-occurring mental health concerns.
Eligible patients who need a structured living environment while attending PHP may use Brooks’ supportive housing in Tullahoma.
For eligible individuals who no longer require intensive clinical treatment but continue to benefit from accountability and a recovery-focused environment, Brooks provides sober living in Tullahoma.
Continued recovery planning can also involve outpatient clinical care, appropriate medication follow-up, peer support, family involvement, community recovery resources, and ongoing strategies for managing anxiety or other triggers without returning to problematic substance use.
At Brooks Healing Center, benzodiazepine addiction treatment is designed around safety, individualized care, and long-term recovery. Our clinical campus is located in Normandy, Tennessee, south of Nashville, past murfreesboro, and serves people throughout Middle Tennessee and surrounding regions.
Our programs and treatment services can include:
Medication management may still be part of benzodiazepine withdrawal or treatment when clinically appropriate.
Brooks is accredited by The Joint Commission and licensed by the Tennessee Department of Mental Health and Substance Abuse Services. View Brooks Healing Center’s licensure and credentials.
Many health insurance plans provide benefits for substance use disorder treatment, although exact coverage depends on the individual plan, medical necessity, recommended level of care, network status, deductible, coinsurance, and authorization requirements.
Brooks’ admissions team can verify your insurance benefits before admission and explain the information provided by your insurance carrier.
Insurance verification is not a guarantee of payment, but it can help patients and families understand what benefits may be available before treatment begins.
Benzodiazepine dependence can develop gradually, and needing help does not necessarily mean someone intentionally misused a prescription. What matters is recognizing when withdrawal, escalating use, illicit pills, other substance use, repeated unsuccessful attempts to stop, or loss of control have made professional support appropriate.
Brooks Healing Center provides benzodiazepine detox and addiction treatment in Tennessee through medical withdrawal support, residential treatment, individualized therapy, dual-diagnosis care when appropriate, PHP, supportive housing, sober living, and continuing recovery planning.
Call Brooks Healing Center at (931) 486-8824 to speak with admissions.
How long benzodiazepines remain detectable depends on the specific medication, dose, frequency and duration of use, metabolism, and testing method. Shorter-acting benzodiazepines generally clear more quickly than longer-acting medications, but withdrawal symptoms may continue after a drug is no longer detectable.
Yes, benzodiazepines can become addictive, but physical dependence alone does not mean someone has an addiction.
The brain can adapt to regular benzodiazepine use even when medication is taken as prescribed. Addiction involves a broader pattern of impaired control, cravings, compulsive use, or continued use despite harm.
Yes. Physical dependence can develop during regular therapeutic benzodiazepine use.
Current ASAM guidance emphasizes that physical dependence is an expected physiological adaptation for many people who take benzodiazepines regularly and should be distinguished from addiction or benzodiazepine use disorder.
No. Narcan does not reverse benzodiazepines themselves because naloxone works on opioids.
However, it may still be appropriate during an emergency if fentanyl or another opioid could also be involved. Give naloxone if available and call 911 when someone is unconscious or has slow or abnormal breathing.
Benzodiazepine withdrawal varies considerably. Some acute symptoms occur over days or weeks, while a medically supervised taper may continue for months.
Some people experience symptoms after the most acute phase has ended, particularly following long-term use. There is no single timeline that applies to every patient.
Yes. Severe benzodiazepine withdrawal can be life-threatening, particularly when someone with established physical dependence stops abruptly.
Seizures, delirium, severe confusion, and other complications can occur, which is why significant benzodiazepine dependence should be evaluated medically.
Benzodiazepines may be prescribed for anxiety disorders, panic attacks, insomnia, muscle spasms, seizure disorders, acute alcohol withdrawal, and certain medical procedures.
The appropriate duration of treatment depends on the specific medication, indication, and individual medical situation.
Benzodiazepine withdrawal is generally managed through individualized medical assessment and gradual dose reduction rather than sudden discontinuation.
Supportive treatment may also address sleep, anxiety, physical symptoms, other substance use, and co-occurring mental health conditions. The taper should be adjusted according to the person’s response.
Some medically stable patients can complete a gradual outpatient taper under the supervision of an appropriate healthcare provider. Others may require structured detox because of previous seizures, severe dependence, polysubstance use, psychiatric instability, an uncertain illicit pill supply, or other medical concerns.
A medically managed outpatient taper is not the same thing as suddenly stopping benzodiazepines at home.
Yes. Brooks provides medical benzodiazepine detox and withdrawal stabilization for clinically appropriate adults at our Normandy, Tennessee campus.
Treatment recommendations are individualized according to the benzodiazepine involved, dose, duration, physical dependence, previous withdrawal, other substances, medical needs, and overall clinical presentation.
Yes. Clinically appropriate patients can transition from detox into residential addiction treatment within the Brooks continuum.
Residential care can address substance-use patterns, anxiety, trauma, emotional regulation, coping, relapse prevention, co-occurring concerns, and the broader factors contributing to continued benzodiazepine misuse.
Yes. A pill sold as Xanax outside a regulated pharmacy may contain a different benzodiazepine, a designer drug such as bromazolam, fentanyl, or multiple unexpected substances.
Color, shape, markings, or packaging cannot reliably establish that an illicit pill contains legitimate alprazolam.
Many insurance plans provide benefits for medically necessary substance use disorder treatment, but coverage varies according to the policy, level of care, medical necessity, network status, deductible, coinsurance, and authorization requirements.
Brooks can verify insurance benefits before admission.
